Frazier Life Sciences VIII, L.P. 4

Accession 0001104659-18-042315

CIK 0001674365other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:56 PM ET

Size

22.6 KB

Accession

0001104659-18-042315

Form 4

Period: 2018-06-25

10% Owner

Transactions

Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total
Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See Footnote)
→ Common Stock (1,047,450 underlying)
Conversion
Series B Convertible Preferred Stock
2018-06-25−21,946,301→ 0 total(indirect: See Footnote)
→ Common Stock (795,553 underlying)
Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total
Purchase
Common Stock
2018-06-25$16.00/sh+150,000$2,400,000→ 3,190,079 total
Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See Footnote)
→ Common Stock (1,197,076 underlying)
Conversion
Common Stock
2018-06-25+795,553→ 3,040,079 total

10% Owner

Transactions

Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total
Purchase
Common Stock
2018-06-25$16.00/sh+150,000$2,400,000→ 3,190,079 total
Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See Footnote)
→ Common Stock (1,047,450 underlying)
Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total
Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See Footnote)
→ Common Stock (1,197,076 underlying)
Conversion
Common Stock
2018-06-25+795,553→ 3,040,079 total
Conversion
Series B Convertible Preferred Stock
2018-06-25−21,946,301→ 0 total(indirect: See Footnote)
→ Common Stock (795,553 underlying)

10% Owner

Transactions

Conversion
Common Stock
2018-06-25+795,553→ 3,040,079 total
Purchase
Common Stock
2018-06-25$16.00/sh+150,000$2,400,000→ 3,190,079 total
Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See Footnote)
→ Common Stock (1,047,450 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See Footnote)
→ Common Stock (1,197,076 underlying)
Conversion
Series B Convertible Preferred Stock
2018-06-25−21,946,301→ 0 total(indirect: See Footnote)
→ Common Stock (795,553 underlying)
Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total
Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total

10% Owner

Transactions

Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total
Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total
Conversion
Common Stock
2018-06-25+795,553→ 3,040,079 total
Purchase
Common Stock
2018-06-25$16.00/sh+150,000$2,400,000→ 3,190,079 total
Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See Footnote)
→ Common Stock (1,047,450 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See Footnote)
→ Common Stock (1,197,076 underlying)
Conversion
Series B Convertible Preferred Stock
2018-06-25−21,946,301→ 0 total(indirect: See Footnote)
→ Common Stock (795,553 underlying)

Footnotes (3)

[F1]Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.
[F2]The shares are held directly by Frazier Life Sciences VIII, L.P. ("FLS-VIII") and this report is filed jointly by Frazier Life Sciences VIII, L.P. ("FLS-VIII L.P."), FHM Life Sciences VIII, L.P. (FHM-VIII L.P."), FHM Life Sciences VIII, L.L.C. ("FHM-VIII LLC") and Patrick J. Heron. Shares are held directly by FLS-VIII. FHM-VIII L.P. serves as the sole general partner of FLS-VIII and owns no shares directly. FHM-VIII LLC serves as the sole general partner of FHM-VIII L.P. and owns no shares directly. Mr. Heron and James Topper are members of FHM-VIII LLC and share voting and dispositive power over the shares held by FLS-VIII; however, they disclaim beneficial ownership of the shares held by FLS-VIII except to the extent of their pecuniary interests therein.
[F3]On June 25, 2018, FLS-VIII purchased 150,000 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.

Documents

1 file

Aptinyx Inc.

CIK 0001674365

Entity typeother

IncorporatedDE